Related Experiment Video

Updated: Aug 7, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Antizyme inhibitor: mysterious modulator of cell proliferation

U Mangold1

  • 1Program in Vascular Biology, Children's Hospital, Karp Family Building, 1 Blackfan Circle, Boston, Massachusetts 02115, USA. ursula.mangold@childrens.harvard.edu

Cellular and Molecular Life Sciences : CMLS
|July 19, 2006
PubMed

Insights

Antizyme inhibitor (AZI) is less studied than ornithine decarboxylase (ODC) and antizymes. AZI may promote tumor progression by inactivating antizymes and reactivating ODC.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ornithine decarboxylase (ODC) and antizymes are key regulators of cell proliferation and tumorigenesis.
  • Elevated ODC activity is linked to human malignancies.
  • Antizyme inhibitor (AZI), homologous to ODC, has been understudied.

Purpose of the Study:

  • To investigate the role of antizyme inhibitor (AZI) in cancer.
  • To understand AZI's interaction with ODC and antizymes.

Main Methods:

  • Biochemical assays to study enzyme activity and protein interactions.
  • Analysis of ODC and antizyme family member interactions with AZI.

Main Results:

  • AZI inactivates antizymes, including antizyme 1.
  • AZI reactivates ODC activity.
  • AZI prevents ODC degradation by antizymes.

Conclusions:

  • AZI's functions suggest a role in promoting tumor progression.
  • Further research into AZI is warranted for cancer therapy development.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.